Literature DB >> 23678469

Association of Expanded Disability Status Scale and Cytokines after Intervention with Co-supplemented Hemp Seed, Evening Primrose Oils and Hot-natured Diet in Multiple Sclerosis Patients(♦).

Soheila Rezapour-Firouzi1, Seyed Rafie Arefhosseini, Mehdi Farhoudi, Mehrangiz Ebrahimi-Mamaghani, Mohammad-Reza Rashidi, Mohammad-Ali Torbati, Behzad Baradaran.   

Abstract

INTRODUCTION: Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS). Because of limited efficacy and adverse side effects, identifying novel therapeutic and protective agents is important. The aim of this study is to examine the correlations between expanded disability status scale (EDSS) and cytokines after intervention with co-supplemented hemp seed and evening primrose oils and hot-natured diet in patients with relapsing-remitting multiple sclerosis (RRMS).
METHODS: We studied a group of 23 patients with clinically definite RRMS, with EDSS<6 who received co-supplemented hemp seed and evening primrose oils with advising hot-natured diet. Clinically EDSS and immunological factors (plasma cytokines of IL-4, IFN-γ and IL-17) were assessed at baseline and after 6 months.
RESULTS: Mean follow-up was 180±2.9 days (N=23, 7 Male and 16 Females aged 25.0±7.5 years with disease duration 6.26±3.9 years). After 6 months, significant improvements in extended disability status score were found in the patients in agreement with decrease cytokines of IFN-γ and IL-17 and increase cytokines of IL-4. Clinical and immunological parameters showed improvement in the patients after the intervention.
CONCLUSION: Our study shows that co-supplemented hemp seed and evening primrose oils with hot-natured diet can have beneficial effects in improving clinical symptoms in relapsing remitting MS patients and significant correlation was found between EDSS and immunological findings.

Entities:  

Keywords:  Cannabis sativa L.; Evening Primrose; Hemp seed; Hot-natured Diet; Inflammation; Multiple Sclerosis; Oenothera biennis L.; Therapy

Year:  2012        PMID: 23678469      PMCID: PMC3648912          DOI: 10.5681/bi.2013.001

Source DB:  PubMed          Journal:  Bioimpacts        ISSN: 2228-5652


  30 in total

1.  The generation of Th memory in neonates versus adults: prolonged primary Th2 effector function and impaired development of Th1 memory effector function in murine neonates.

Authors:  B Adkins; Y Bu; P Guevara
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

Review 2.  Blood-brain barrier disruption in multiple sclerosis.

Authors:  Alireza Minagar; J Steven Alexander
Journal:  Mult Scler       Date:  2003-12       Impact factor: 6.312

Review 3.  Cytokines in multiple sclerosis: from bench to bedside.

Authors:  Jaime Imitola; Tanuja Chitnis; Samia J Khoury
Journal:  Pharmacol Ther       Date:  2005-01-11       Impact factor: 12.310

4.  A mechanism for the initiation of allergen-induced T helper type 2 responses.

Authors:  Caroline L Sokol; Gregory M Barton; Andrew G Farr; Ruslan Medzhitov
Journal:  Nat Immunol       Date:  2008-03       Impact factor: 25.606

5.  Understanding the IL-23-IL-17 immune pathway.

Authors:  Brent S McKenzie; Robert A Kastelein; Daniel J Cua
Journal:  Trends Immunol       Date:  2005-11-14       Impact factor: 16.687

6.  CD4+CD25high regulatory cells in human peripheral blood.

Authors:  C Baecher-Allan; J A Brown; G J Freeman; D A Hafler
Journal:  J Immunol       Date:  2001-08-01       Impact factor: 5.422

Review 7.  Traditional pharmacological treatments for spasticity. Part II: General and regional treatments.

Authors:  J M Gracies; P Nance; E Elovic; J McGuire; D M Simpson
Journal:  Muscle Nerve Suppl       Date:  1997

8.  Oral administration of myelin induces antigen-specific TGF-beta 1 secreting T cells in patients with multiple sclerosis.

Authors:  D A Hafler; S C Kent; M J Pietrusewicz; S J Khoury; H L Weiner; H Fukaura
Journal:  Ann N Y Acad Sci       Date:  1997-12-19       Impact factor: 5.691

9.  Human IL-17: a novel cytokine derived from T cells.

Authors:  Z Yao; S L Painter; W C Fanslow; D Ulrich; B M Macduff; M K Spriggs; R J Armitage
Journal:  J Immunol       Date:  1995-12-15       Impact factor: 5.422

10.  Cytokine secretion and eicosanoid production in the peripheral blood mononuclear cells of MS patients undergoing dietary supplementation with n-3 polyunsaturated fatty acids.

Authors:  V Gallai; P Sarchielli; A Trequattrini; M Franceschini; A Floridi; C Firenze; A Alberti; D Di Benedetto; E Stragliotto
Journal:  J Neuroimmunol       Date:  1995-02       Impact factor: 3.478

View more
  6 in total

Review 1.  Multifaceted regulation and functions of fatty acid desaturase 2 in human cancers.

Authors:  Yan-Ling Li; Hao Tian; Jun Jiang; Yi Zhang; Xiao-Wei Qi
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

Review 2.  Managing Disability in Progressive Multiple Sclerosis.

Authors:  Divyanshu Dubey; Peter Sguigna; Olaf Stüve
Journal:  Curr Treat Options Neurol       Date:  2016-06       Impact factor: 3.598

Review 3.  The seed of industrial hemp (Cannabis sativa L.): Nutritional Quality and Potential Functionality for Human Health and Nutrition.

Authors:  Barbara Farinon; Romina Molinari; Lara Costantini; Nicolò Merendino
Journal:  Nutrients       Date:  2020-06-29       Impact factor: 5.717

4.  Combination therapy using evening primrose oil and electrical stimulation to improve nerve function following a crush injury of sciatic nerve in male rats.

Authors:  Omid Badri; Parviz Shahabi; Jalal Abdolalizadeh; Mohammad Reza Alipour; Hadi Veladi; Mehdi Farhoudi; Mohsen Sharif Zak
Journal:  Neural Regen Res       Date:  2017-03       Impact factor: 5.135

5.  The effect of evening primrose oil on fatigue and quality of life in patients with multiple sclerosis.

Authors:  Nastaran Majdinasab; Foroogh Namjoyan; Mohsen Taghizadeh; Hamid Saki
Journal:  Neuropsychiatr Dis Treat       Date:  2018-06-12       Impact factor: 2.570

Review 6.  The Sources of Essential Fatty Acids for Allergic and Cancer Patients; a Connection with Insight into Mammalian Target of Rapamycin: A Narrative Review

Authors:  Zhila Arshad; Soheila Rezapour-Firouzi; Mahshid Mohammadian
Journal:  Asian Pac J Cancer Prev       Date:  2018-09-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.